ASD-NP6 is a novel formulation of intestinally absorbed oral alpha-cyclodextrin as a unique 'intermittent fasting mimetic' (CoM pat. pend) to promote healthy aging
by

- Maintaining lysosomal function

- Restoring autophaging,
   (ie, reducing garbaging) and

- Reducing inflammaging.

The MoA of ASD-NP6 was proven to improve age-related functions in several in-vivo and clinical studies.